Skip to Content
U.S. National Institutes of Health
Cancer Diagnosis Program Cancer Imaging Program Cancer Therapy Evaluation Program Developmental Therapeutics Program Radiation Research Program Translational Research Program Biometric Research Branch Office of Cancer Complementary and Alternative Medicine

Major Initiatives:

NCI-sponsored Trials in Precision Medicine
Genes code for information that allows normal growth and development. In cancer, these processes work abnormally, leading to abnormal growth and spread of cancerous disease. Even cancers that are thought of as similar (e.g. lung cancer) have been found to consist of cancers with different molecular make up, and different rates of progress and response to treatment. More…

Spotlight on:

DCTD Programs

Cancer Diagnosis Program Cancer Diagnosis Program
Funds specimen resources and research to characterize tumors
Radiation Research Program Radiation Research Program
Funds novel radiotherapy research
Cancer Imaging Program Cancer Imaging Program
Evaluates imaging in diagnosis, disease staging, and treatment monitoring
Translational Research Program Translational Research Program
Integrates scientific advancements in the understanding of the biology of human cancer
Cancer Therapy Evaluation Program Cancer Therapy Evaluation Program
Assesses new anticancer agents, radiation treatments, and surgical methods
Biometric Research Branch Biometric Research Branch
Provides statistical and biomathematical analyses
Developmental Therapeutics Program Developmental Therapeutics Program
Funds drug discovery and development and provides related services
Office of Cancer Complementary and Alternative Medicine Office of Cancer Complementary and Alternative Medicine
Improves the quality of cancer research on complementary and alternative modalities